After the identification of LMO2 as a proto-oncogene in T-ALL, the natural function of the protein was investigated in mouse and human cells to delineate its normal biochemistry and to instruct future work on development of anti-LMO2 therapies. Here, LMO2 is linked to acute lymphoblastic leukemia.